Department of Biochemistry and Cell Biology, Stony Brook University, New York, United States.
Department of Pharmacology, University of Minnesota Medical School, New York, United States.
Elife. 2018 Aug 9;7:e36654. doi: 10.7554/eLife.36654.
VivosX is an disulfide crosslinking approach that utilizes a pair of strategically positioned cysteines on two proteins to probe physical interactions within cells. Histone H2A.Z, which often replaces one or both copies of H2A in nucleosomes downstream of promoters, was used to validate VivosX. Disulfide crosslinks between cysteine-modified H2A.Z and/or H2A histones within nucleosomes were induced using a membrane-permeable oxidant. VivosX detected different combinations of H2A.Z and H2A within nucleosomes in yeast cells. This assay correctly reported the change in global H2A.Z occupancy previously observed when the deposition and eviction pathways of H2A.Z were perturbed. Homotypic H2A.Z/H2A.Z (ZZ) nucleosomes accumulated when assembly of the transcription preinitiation complex was blocked, revealing that the transcription machinery preferentially disassembles ZZ nucleosomes. VivosX works in human cells and distinguishes ZZ nucleosomes with one or two ubiquitin moieties, demonstrating that it can be used to detect protein-protein interactions inside cells from different species.
VivosX 是一种二硫键交联方法,利用两个蛋白质上的一对策略性定位半胱氨酸来探测细胞内的物理相互作用。组蛋白 H2A.Z 常用于验证 VivosX,它通常在启动子下游的核小体中取代 H2A 的一个或两个拷贝。使用膜透性氧化剂诱导半胱氨酸修饰的 H2A.Z 和/或核小体中 H2A 组蛋白之间的二硫键交联。VivosX 在酵母细胞中检测到核小体中 H2A.Z 和 H2A 的不同组合。当 H2A.Z 的沉积和逐出途径受到干扰时,该测定法正确报告了先前观察到的全局 H2A.Z 占有率的变化。当转录起始复合物的组装被阻断时,同源 H2A.Z/H2A.Z(ZZ)核小体积累,表明转录机制优先拆卸 ZZ 核小体。VivosX 在人类细胞中起作用,并区分带有一个或两个泛素基团的 ZZ 核小体,证明它可用于检测来自不同物种的细胞内的蛋白质-蛋白质相互作用。